CDKN2A and neoplasm: In CRC primary tumours, the hypermethylation of bone morphogenetic protein 2 (BMP2), cyclin-dependent kinase inhibitor 2A (CDKN2A), and family with sequence similarity 134 member B (FAM134B) was associated with lymph node metastases [55,56,57].